Zobrazeno 1 - 5
of 5
pro vyhledávání: '"intercalated treatment"'
Publikováno v:
Radiology and Oncology, Vol 51, Iss 3, Pp 241-251 (2017)
When treating patients with advanced non-small cell lung cancer (NSCLC) with tyrosine kinase inhibitors and chemotherapy, intercalated schedule with time separation between the two classes of drugs should avoid their mutual antagonism. In a survey of
Externí odkaz:
https://doaj.org/article/b90f0da0e80c4cc792ac29eb1d5399c7
Publikováno v:
Radiology and Oncology
Radiology and oncology (Ljubljana)
Radiology and Oncology, Vol 51, Iss 3, Pp 241-251 (2017)
Radiology and oncology (Ljubljana)
Radiology and Oncology, Vol 51, Iss 3, Pp 241-251 (2017)
Background When treating patients with advanced non-small cell lung cancer (NSCLC) with tyrosine kinase inhibitors and chemotherapy, intercalated schedule with time separation between the two classes of drugs should avoid their mutual antagonism. In
Autor:
Kovac, Grmek M, M. Rajer, Karmen Stanic, Izidor Kern, M Vrankar, Doma A, M Zwitter, Cuderman A
Publikováno v:
Cancer Biology & Therapy
Among attempts to delay development of resistance to tyrosine kinase inhibitors (TKIs) in patients with advanced non-small cell lung cancer (NSCLC) with activating mutations of epidermal growth factor receptor (EGFR), intercalated therapy has not bee
Publikováno v:
Radiology and Oncology, vol. 51, no. 3, pp. 241-251, 2017.
Background: When treating patients with advanced non-small cell lung cancer (NSCLC) with tyrosine kinase inhibitors and chemotherapy, intercalated schedule with time separation between the two classes of drugs should avoid their mutual antagonism. In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1857::b463003b2451207e951543839492634a
https://dk.um.si/Dokument.php?id=119945&dn=
https://dk.um.si/Dokument.php?id=119945&dn=
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.